Business Context and Reporting Period
Company: Axcelis Technologies, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2009
Industry: Semiconductor Manufacturing Equipment (Ion Implantation and Dry Strip systems)
Overview: Axcelis designs, manufactures, and services equipment for semiconductor chip fabrication. In 2009, the company operated in a severely depressed market characterized by reduced capital spending by semiconductor manufacturers. A significant strategic event in 2009 was the divestiture of the company's 50% interest in SEN Corporation, a joint venture in Japan, which was sold to Sumitomo Heavy Industries, Ltd. on March 30, 2009.
Key Financial Metrics
| Metric | 2009 | 2008 | 2007 |
|---|---|---|---|
| Revenue | $133.0 million | $250.2 million | $404.8 million |
| Gross Profit | $28.1 million | $62.6 million | $152.9 million |
| Gross Margin | 21.1% | 25.0% | 37.8% |
| Net Loss | $(77.5) million | $(196.7) million | $(11.4) million |
| Net Loss Per Share (Basic/Diluted) | $(0.75) | $(1.91) | $(0.11) |
| Cash and Cash Equivalents (Year End) | $45.0 million | $37.7 million | $83.9 million |
| Working Capital | $163.8 million | $111.2 million | $284.7 million |
| Long-Term Liabilities | $4.4 million | $5.8 million | $89.9 million |
| Research & Development | $32.7 million (24.6% of Rev) | $63.3 million (25.3% of Rev) | $72.0 million (17.8% of Rev) |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 46.8% from 2008 to 2009, driven by a significant downturn in the semiconductor equipment market and reduced capital spending by customers. Product revenue fell from $194.3 million to $98.7 million.
- Improved Net Loss: While the company remained unprofitable, the net loss improved significantly from $196.7 million in 2008 to $77.5 million in 2009. This improvement was largely due to the absence of massive impairment charges recorded in 2008 (goodwill and long-lived assets totaling $89 million) and aggressive cost-cutting measures.
- Debt Elimination: Proceeds from the sale of the SEN investment ($122.2 million net) were used to fully repay the company's 4.25% Convertible Senior Subordinated Notes, eliminating a significant debt obligation and reducing interest expense.
- Restructuring: The company incurred $5.5 million in restructuring charges in 2009, primarily for severance and outplacement costs associated with a workforce reduction of approximately 20%.
- Asset Impairment: Unlike 2008, no impairment charges were recorded for long-lived assets in 2009, as management determined the carrying amounts were recoverable based on updated forecasts.
Guidance, Outlook, and Risks
- Outlook: Management expects revenue and cash flow to improve in 2010, citing signs of market recovery in the fourth quarter of 2009 and increasing capacity utilization at customer facilities. The company plans to maintain operating expense levels consistent with the end of 2009.
- Liquidity: As of December 31, 2009, the company held $45.0 million in cash and cash equivalents. Management believes this is sufficient to satisfy anticipated cash requirements through 2010. A $20 million revolving credit facility was amended in March 2010 to provide additional liquidity.
- Key Risks:
- Cyclicality: The semiconductor industry is highly cyclical; a failure of the market to recover in 2010 could materially affect liquidity entering 2011.
- Customer Concentration: The top 10 customers accounted for 56.6% of revenue in 2009. Loss of a significant customer could materially harm sales.
- Market Share: Success is heavily dependent on gaining market share with the Optima HDx high current implant system, where the company was late to market.
- Intellectual Property: Risks include patent infringement claims and the ability to protect proprietary technology against competitors.
Investor Verification Checklist
- Market Recovery: Verify if the semiconductor equipment market recovery in 2010 meets the industry forecasts assumed by management.
- Optima HDx Adoption: Monitor sales traction and market share gains for the Optima HDx high current implant system, which is critical to future growth.
- Liquidity Covenants: Review compliance with the financial covenants of the amended $20 million credit facility (Adjusted Quick Ratio, Maximum Losses, and Liquidity requirements).
- Inventory Levels: Assess the adequacy of inventory reserves given the high level of inventory ($114.6 million) relative to the depressed sales volume.
- Customer Concentration: Track the stability of the top 10 customers, who represent over half of total revenue.